A newly discovered gene switch may help turn chemotherapy-resistant pancreatic cancer into a treatable disease.
A team of researchers from Taiwan has developed PanMETAI, an AI-powered platform that analyzes metabolic fingerprints in a ...
THE WOODLANDS, TX, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (AMIX) (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision ...
The FDA has approved a first-of-its-kind wearable electrical device — Optune Pax (Novocure) — for patients with locally advanced pancreatic cancer, in combination with gemcitabine and nab-paclitaxel.
The FDA approved a tumor treating fields (TTFields) device for locally advanced pancreatic cancer, the first therapy approved in this setting in nearly 30 years. Dubbed Optune Pax, the wearable device ...
Please provide your email address to receive an email when new articles are posted on . FDA has approved a portable device for patients with locally advanced pancreatic cancer. A phase 3 trial showed ...
Stress signals redesign tissues during inflammation and cancer. Left: Normal tissue maintenance. Right: Stress signals “switch on” fibroblasts, turning them into myCAFs (purple) that actively recruit ...
Notoriously tricky to detect, pancreatic cancer also often resists traditional therapy. So, researchers are urgently looking for new ways to disrupt tumor formation. Though scientists know that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results